Cargando…
Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange
BACKGROUND: Acellular Pertussis vaccines against whooping cough caused by Bordetella pertussis present a much-improved safety profile compared to the original vaccine of killed whole cells. The principal antigen of acellular Pertussis vaccine, Pertussis Toxin (PT), must be chemically inactivated to...
Autores principales: | Buasri, Wasin, Impoolsup, Attawut, Boonchird, Chuenchit, Luengchaichawange, Anocha, Prompiboon, Pannipa, Petre, Jean, Panbangred, Watanalai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349578/ https://www.ncbi.nlm.nih.gov/pubmed/22524455 http://dx.doi.org/10.1186/1471-2180-12-61 |
Ejemplares similares
-
Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin
por: Williams, Margaret M., et al.
Publicado: (2016) -
Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis
por: Ma, Longhuan, et al.
Publicado: (2021) -
Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986–2018
por: Mir-Cros, Alba, et al.
Publicado: (2022) -
Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan
por: Otsuka, Nao, et al.
Publicado: (2012) -
Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia
por: Lam, Connie, et al.
Publicado: (2014)